In HCC, leucine rich repeat containing G protein-coupled receptor 5 bound and blocked the nuclear translocation of programmed cell death protein 5, reducing the stability of TP53 and promoting the degradation of TP53, thus promoting EMT and the drug resistance of HCC cells to doxorubicin [48]. Here, PDCD5 is linked to hepatocellular carcinoma.